Biogen Inc. buy Royal Bank of Canada
Start price
12.02.24
/
50%
€226.20
Target price
12.02.25
€351.83
Performance (%)
-43.30%
End price
13.02.25
€128.25
Summary
This prediction ended on 13.02.25 with a price of €128.25. Massive losses of -43.30% were the result for the BUY prediction by Royal_Bank_of_Canada. Royal_Bank_of_Canada has a follow-up prediction for Biogen Inc. where he still thinks Biogen Inc. is a Buy. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | 4.318% | 4.318% | -46.012% |
| iShares Core DAX® | -1.315% | -2.266% | 28.038% |
| iShares Nasdaq 100 | 0.272% | 1.449% | 3.927% |
| iShares Nikkei 225® | -2.496% | 1.560% | -0.594% |
| iShares S&P 500 | 0.504% | 1.340% | 4.568% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target raised by analysts at Royal Bank of Canada from $363.00 to $379.00. They now have an "overweight" rating on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten